Disparities in fertility preservation use among adolescent and young adult women with cancer
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
PURPOSE: Women face multiple barriers to fertility preservation after cancer diagnosis, but few studies have examined disparities in use of these services.
METHODS: Women aged 15-39 years diagnosed with cancer during 2004-2015 were identified from the North Carolina Central Cancer Registry and linked to the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Women who cryopreserved oocytes or embryos for fertility preservation (n = 96) were compared to women who received gonadotoxic treatment but did not use fertility preservation (n = 7964). Conditional logistic and log-binomial regression were used to estimate odds ratios (ORs) or prevalence ratios (PRs) and 95% confidence intervals (CIs).
RESULTS: Few adolescent and young adult women with cancer in our study (1.2%) used fertility preservation. In multivariable regression, women less likely to use fertility preservation were older at diagnosis (ages 25-29 vs. 35-39: OR = 6.27, 95% CI: 3.35, 11.73); non-Hispanic Black (vs. non-Hispanic White: PR = 0.44, 95% CI: 0.24, 0.79); and parous at diagnosis (vs. nulliparous: PR = 0.24, 95% CI: 0.13, 0.45); or lived in census tracts that were non-urban (vs. urban: PR = 0.12, 95% CI: 0.04, 0.37) or of lower socioeconomic status (quintiles 1-3 vs. quintiles 4 and 5: PR = 0.39, 95% CI: 0.25, 0.61).
CONCLUSIONS: Women with cancer who were older, non-Hispanic Black, parous, or living in areas that were non-urban or of lower socioeconomic position were less likely to use fertility preservation.
IMPLICATIONS FOR CANCER SURVIVORS: Clinical and policy interventions are needed to ensure equitable access to fertility services among women facing cancer treatment-related infertility.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Journal of cancer survivorship : research and practice - 17(2023), 5 vom: 15. Okt., Seite 1435-1444 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Meernik, Clare [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer survivors |
|---|
| Anmerkungen: |
Date Completed 22.08.2023 Date Revised 05.09.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11764-022-01187-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337019533 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337019533 | ||
| 003 | DE-627 | ||
| 005 | 20231225233449.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11764-022-01187-y |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1123.xml |
| 035 | |a (DE-627)NLM337019533 | ||
| 035 | |a (NLM)35169982 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Meernik, Clare |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Disparities in fertility preservation use among adolescent and young adult women with cancer |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.08.2023 | ||
| 500 | |a Date Revised 05.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
| 520 | |a PURPOSE: Women face multiple barriers to fertility preservation after cancer diagnosis, but few studies have examined disparities in use of these services | ||
| 520 | |a METHODS: Women aged 15-39 years diagnosed with cancer during 2004-2015 were identified from the North Carolina Central Cancer Registry and linked to the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Women who cryopreserved oocytes or embryos for fertility preservation (n = 96) were compared to women who received gonadotoxic treatment but did not use fertility preservation (n = 7964). Conditional logistic and log-binomial regression were used to estimate odds ratios (ORs) or prevalence ratios (PRs) and 95% confidence intervals (CIs) | ||
| 520 | |a RESULTS: Few adolescent and young adult women with cancer in our study (1.2%) used fertility preservation. In multivariable regression, women less likely to use fertility preservation were older at diagnosis (ages 25-29 vs. 35-39: OR = 6.27, 95% CI: 3.35, 11.73); non-Hispanic Black (vs. non-Hispanic White: PR = 0.44, 95% CI: 0.24, 0.79); and parous at diagnosis (vs. nulliparous: PR = 0.24, 95% CI: 0.13, 0.45); or lived in census tracts that were non-urban (vs. urban: PR = 0.12, 95% CI: 0.04, 0.37) or of lower socioeconomic status (quintiles 1-3 vs. quintiles 4 and 5: PR = 0.39, 95% CI: 0.25, 0.61) | ||
| 520 | |a CONCLUSIONS: Women with cancer who were older, non-Hispanic Black, parous, or living in areas that were non-urban or of lower socioeconomic position were less likely to use fertility preservation | ||
| 520 | |a IMPLICATIONS FOR CANCER SURVIVORS: Clinical and policy interventions are needed to ensure equitable access to fertility services among women facing cancer treatment-related infertility | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Cancer survivors | |
| 650 | 4 | |a Cryopreservation | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Fertility preservation | |
| 700 | 1 | |a Engel, Stephanie M |e verfasserin |4 aut | |
| 700 | 1 | |a Wardell, Ally |e verfasserin |4 aut | |
| 700 | 1 | |a Baggett, Christopher D |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Parul |e verfasserin |4 aut | |
| 700 | 1 | |a Rodriguez-Ormaza, Nidia |e verfasserin |4 aut | |
| 700 | 1 | |a Luke, Barbara |e verfasserin |4 aut | |
| 700 | 1 | |a Baker, Valerie L |e verfasserin |4 aut | |
| 700 | 1 | |a Wantman, Ethan |e verfasserin |4 aut | |
| 700 | 1 | |a Rauh-Hain, Jose Alejandro |e verfasserin |4 aut | |
| 700 | 1 | |a Mersereau, Jennifer E |e verfasserin |4 aut | |
| 700 | 1 | |a Olshan, Andrew F |e verfasserin |4 aut | |
| 700 | 1 | |a Smitherman, Andrew B |e verfasserin |4 aut | |
| 700 | 1 | |a Cai, Jianwen |e verfasserin |4 aut | |
| 700 | 1 | |a Nichols, Hazel B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cancer survivorship : research and practice |d 2007 |g 17(2023), 5 vom: 15. Okt., Seite 1435-1444 |w (DE-627)NLM181109514 |x 1932-2267 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2023 |g number:5 |g day:15 |g month:10 |g pages:1435-1444 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11764-022-01187-y |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2023 |e 5 |b 15 |c 10 |h 1435-1444 | ||